Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Trends in Immunology
|
February 9, 2008
Novel strategies to eliminate persistent viral infections
Marianne M Martinic, Matthias G von Herrath
European Journal of Immunology
|
September 5, 2006
Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity?
Marianne M Martinic, Matthias G von Herrath
Immunological Reviews
|
February 16, 2008
Real-time imaging of the pancreas during development of diabetes
Marianne M Martinic, Matthias G von Herrath
Plos One
|
January 5, 2011
A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy
Ken Coppieters, Marianne M Martinic, William B Kiosses, et al.
European Journal of Immunology
|
March 30, 2004
Role of TCR-restricting MHC density and thymic environment on selection and survival of cells expressing low-affinity T cell receptors
Marianne M Martinic, Benedita Rocha, Kathy D McCoy, et al.
Innovations in Clinical Neuroscience
|
June 20, 2019
Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis
Laetitia Pouzol, Luca Piali, Claude Ca Bernard, et al.
Blood
|
April 9, 2004
Do thymically and strictly extrathymically developing T cells generate similar immune responses?
Marie-Eve Blais, Gwladys Gérard, Marianne M Martinic, et al.
Frontiers in Pharmacology
|
November 22, 2021
CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis
Laetitia Pouzol, Anna Sassi, Nadège Baumlin, et al.
Journal of Autoimmunity
|
October 12, 2010
Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis
Marianne M Martinic, Christoph Huber, Ken Coppieters, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 17, 2021
ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases
Laetitia Pouzol, Nadège Baumlin, Anna Sassi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Trends in Immunology
|
February 9, 2008
Novel strategies to eliminate persistent viral infections
Marianne M Martinic, Matthias G von Herrath
European Journal of Immunology
|
September 5, 2006
Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity?
Marianne M Martinic, Matthias G von Herrath
Immunological Reviews
|
February 16, 2008
Real-time imaging of the pancreas during development of diabetes
Marianne M Martinic, Matthias G von Herrath
Plos One
|
January 5, 2011
A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy
Ken Coppieters, Marianne M Martinic, William B Kiosses, et al.
European Journal of Immunology
|
March 30, 2004
Role of TCR-restricting MHC density and thymic environment on selection and survival of cells expressing low-affinity T cell receptors
Marianne M Martinic, Benedita Rocha, Kathy D McCoy, et al.
Innovations in Clinical Neuroscience
|
June 20, 2019
Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis
Laetitia Pouzol, Luca Piali, Claude Ca Bernard, et al.
Blood
|
April 9, 2004
Do thymically and strictly extrathymically developing T cells generate similar immune responses?
Marie-Eve Blais, Gwladys Gérard, Marianne M Martinic, et al.
Frontiers in Pharmacology
|
November 22, 2021
CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis
Laetitia Pouzol, Anna Sassi, Nadège Baumlin, et al.
Journal of Autoimmunity
|
October 12, 2010
Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis
Marianne M Martinic, Christoph Huber, Ken Coppieters, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 17, 2021
ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases
Laetitia Pouzol, Nadège Baumlin, Anna Sassi, et al.
Page
of 3